<qa>  What was the first disease phase that received imatinib treatment outside of an MDACCMDACC CML patients July 1, 1998 to September 1, 2017 in any disease phase chronic, accelerated or blast phase that received imatinib treatment outside an MDACC clinical trial prior to a MCACC clinic visit. 